Rhythm Pharmaceuticals, Inc. RYTM Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$196.54M+24.6% | -$260.6M-41.1% | -$184.68M-2.0% | -$181.12M-160% | ||
| $66.82M+68.4% | $39.68M+21.9% | $32.55M+64.2% | $19.83M-4.7% | ||
| -$115.68M-1.6% | -$113.88M+16.4% | -$136.16M+21.5% | -$173.43M-18.8% | ||
| —— | —— | —— | —— | ||
| $19.92M+54.4% | $12.9M+74.4% | $7.4M— | —— | ||
| —— | $191.24M+157% | $74.37M-65.2% | $213.83M+28.4% | ||
| -$36.85M-226% | $29.19M+140% | -$73.62M— | —— | ||
| -$116.63M-2.4% | -$113.88M+16.4% | -$136.2M+21.6% | -$173.71M-18.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Rhythm Pharmaceuticals, Inc. generate?
- Rhythm Pharmaceuticals, Inc. (RYTM) generated -$119.5M in operating cash flow over the trailing twelve months.
- Where does Rhythm Pharmaceuticals, Inc.'s cash flow data come from?
- Every line is extracted from Rhythm Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
